Drug name…or Star Wars planet?
Prescription drugs have weird names. But so do planets in the Star Wars universe. We asked CNBC staffers whether they could tell the difference.
02:04
Fri, Apr 10 20159:30 AM EDT
Similar Posts
Nvidia’s stock has a leg to go much higher, says Freedom Capital’s Jay Woods
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Jay Woods, Freedom Capital Markets chief global strategist, joins ‘Power Lunch’ to discuss the technical support for three stocks making some moves today.
Watch CNBC’s full interview with Charles Schwab’s Liz Ann Sonders, Veritas’ Greg Branch and Virtus’ Joe Terranova
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Liz Ann Sonders, Charles Schwab chief investment strategist, Greg Branch, Veritas Financial Group managing partner, and Joe Terranova, senior managing director at Virtus Investment Partners, join ‘Closing Bell’ to discuss the CPI report, jobs data impact on the markets, and more.
Jim Cramer recaps the year in generative artificial intelligence
CNBC’s Jim Cramer looked back on the year of artificial intelligence and highlighted some ways it has affected the world. “The good news? Generative AI can’t do everything,” Cramer said on his Thursday show. “The bad news? What it can do, it does better than we’ll ever do, unless maybe you’re Einstein or Beethoven or…
What Oprah knows for sure
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email In the series finale, Oprah Winfrey tells Suze she knew from the very first time she was on her show, that Suze was destined to do something special. 03:04 Sat, Mar 28 20159:05 PM EDT
‘Squawk on the Street’ crew react to December’s CPI report
CNBC’s Carl Quintanilla and Jim Cramer break down December’s CPI data.
Final Trades: Uber, URNM, Abbott Labs and Vertex Pharma
Brenda Vingiello, Sand Hill Global Advisors CIO, Bryn Talkington, Requisite Capital Management managing partner, Jim Lebenthal, Cerity Partners chief equity strategist, and Josh Brown, Ritholtz Wealth Management CEO, join CNBC’s ‘Halftime Report’ to share their final trades.
